tiprankstipranks
Advertisement
Advertisement
TG Therapeutics price target raised to $21 from $20 at BofA
PremiumThe FlyTG Therapeutics price target raised to $21 from $20 at BofA
21d ago
TG Therapeutics Earnings Call Signals BRIUMVI Surge
Premium
Company Announcements
TG Therapeutics Earnings Call Signals BRIUMVI Surge
23d ago
Briumvi’s Rapid Commercial Momentum and Upward Sales Guidance Underpin Bancroft’s Buy Rating
Premium
Ratings
Briumvi’s Rapid Commercial Momentum and Upward Sales Guidance Underpin Bancroft’s Buy Rating
24d ago
TGTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsTGTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
27d ago
TG Therapeutics price target raised to $86 from $55 at B. Riley
Premium
The Fly
TG Therapeutics price target raised to $86 from $55 at B. Riley
1M ago
Analyst Tara Bancroft Raises TG Therapeutics Price Target to $75 on Strong Long-Term Briumvi Growth Outlook
Premium
Ratings
Analyst Tara Bancroft Raises TG Therapeutics Price Target to $75 on Strong Long-Term Briumvi Growth Outlook
1M ago
TG Therapeutics price target raised to $83 from $57 at Jefferies
PremiumThe FlyTG Therapeutics price target raised to $83 from $57 at Jefferies
2M ago
TG Therapeutics Shareholders Reject Executive Compensation at Meeting
Premium
Company Announcements
TG Therapeutics Shareholders Reject Executive Compensation at Meeting
3M ago
TG Therapeutics: Buy Rating Reiterated on Briumvi Expansion Strategy, $70 Price Target Unchanged
Premium
Ratings
TG Therapeutics: Buy Rating Reiterated on Briumvi Expansion Strategy, $70 Price Target Unchanged
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100